No Data
No Data
Shareholders in Yifan Pharmaceutical (SZSE:002019) Have Lost 41%, as Stock Drops 4.3% This Past Week
Yifan Pharmaceutical Gets Registration Approval of Ointment in Singapore
Yifan Pharmaceutical Co., Ltd.'s (SZSE:002019) Prospects Need A Boost To Lift Shares
Yifan Pharmaceutical Secures Registration Approval for Neostigmine Methylsulfate Injection
Yifan Pharmaceutical Co., Ltd. (SZSE:002019) Surges 6.4%; Individual Investors Who Own 50% Shares Profited Along With Insiders
Yifan Pharmaceutical (SZSE:002019) Has A Pretty Healthy Balance Sheet
No Data